Results 221 to 230 of about 54,210 (294)
AL Amyloidosis: Current Treatment and Outcomes. [PDF]
Locke M, Nieto M.
europepmc +1 more source
Kinetics of hematologic response in AL amyloidosis: Insights from clinical and cytogenetic subgroup analysis in the daratumumab era. [PDF]
Bazarbachi AH +20 more
europepmc +1 more source
The Effect of Protein Tagging on Aggregation and Phase Separation
ABSTRACT Protein tags are widely used for purification, solubilization, detection, and imaging, yet they can substantially alter protein self‐assembly. This interference is particularly significant for intrinsically disordered proteins and low‐complexity domains, whose aggregation and phase separation are mediated by weak multivalent interactions that ...
Harunobu Saito, Kenji Sugase
wiley +1 more source
Molecular Expression Differences in Specific Blood Mononuclear Cell-Types Identify Patients With AL Amyloidosis. [PDF]
Kaplan D +11 more
europepmc +1 more source
Frequency-adjusted daratumumab-based regimen versus bortezomib/dexamethasone in newly diagnosed AL amyloidosis: a matched-cohort study. [PDF]
Zheng W +6 more
europepmc +1 more source
Abstract Genetics‐informed care is becoming increasingly important in the management of cardiomyopathy (CM). Despite current guidelines recommending genetic testing and counselors, these services are vastly underutilized. To our knowledge, this is the first qualitative study to examine patient perspectives (n = 10) on genetic counselors and cascade ...
Quan M. Bui +9 more
wiley +1 more source
Atypical Presentation of Systemic Amyloid Light Chain (AL) Amyloidosis. [PDF]
Faraci J, Connor JA, Randhawa S.
europepmc +1 more source

